退職給付引当金繰入額、Transfer From Other Components Of Equity To Retained EarningsSSIFRS、持分法適用会社への投資額 - 化学他2件
- 【期間】
| 年度 | 退職給付引当金繰入額 | Transfer From Other Components Of Equity To Retained EarningsSSIFRS | 持分法適用会社への投資額 - 化学 | 研究開発費 | 合併による増加 |
|---|
| 2008/03 | 15.1億 | | - | | - | | 228億 | | - | |
| 2009/03 | 25.3億 | +67.5% | - | | - | | 237億 | +4.3% | - | |
| 2010/03 | 27.6億 | +9% | - | | - | | 240億 | +1.3% | - | |
| 2011/03 | 30.5億 | +10.6% | - | | - | | 249億 | +3.5% | - | |
| 2012/03 | 23億 | -24.5% | - | | - | | 263億 | +5.6% | - | |
| 2013/03 | 14億 | -39.5% | - | | 158億 | | 369億 | +40.3% | 2476億 | |
| 2014/03 | 2.61億 | -81.3% | - | | 185億 | +17.2% | 521億 | +41.4% | - | |
| 2015/03 | -3.01億 | 赤転 | - | | 201億 | +8.9% | 497億 | -4.7% | - | |
| 2016/03 | -4.87億 | 赤拡 | - | | 203億 | +0.7% | 539億 | +8.5% | - | |
| 2017/03 | 8.09億 | 黒転 | - | | 197億 | -2.6% | 540億 | +0.1% | - | |
| 2018/03 | 7.24億 | -10.5% | - | | 248億 | +25.8% | 600億 | +11.2% | - | |
| 2019/03 | -4.73億 | 赤転 | - | | - | | 409億 | -31.8% | - | |
| 2020/03 | -12.4億 | 赤拡 | - | | - | | 454億 | +11% | - | |
| 2021/03 | -13.9億 | 赤拡 | - | | - | | 388億 | -14.5% | - | |
| 2022/03 | -17.9億 | 赤拡 | - | | - | | 395億 | +1.9% | - | |
| 2023/03 | -20.9億 | 赤拡 | - | | - | | 423億 | +6.9% | - | |
| 2024/03 | -13.3億 | 赤縮 | - | | - | | 431億 | +2.1% | - | |
